Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.41 |
| ▸ | STAT1 | P42224 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | GHSR | Q92847 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15510967 | 1.00 | STAT3 (0.41) | STAT3STAT1KCNH2GPR84KDM4E | |
| SCHEMBL3520094 | 1.00 | STAT3 (0.41) | STAT3STAT1KCNH2GPR84KDM4E | |
| SCHEMBL7647119 | 1.00 | STAT3 (0.41) | STAT3STAT1KCNH2GPR84KDM4E | |
| SCHEMBL3522373 | 1.00 | STAT3 (0.41) | STAT3STAT1KCNH2GPR84KDM4E | |
| Hydrochloric Acid SCHEMBL27872840 | 0.99 | STAT3 (0.40) | STAT3STAT1KCNH2GPR84KDM4E | |
| SCHEMBL5133634 | 0.99 | STAT3 (0.42) | STAT3STAT1KCNH2GPR84KDM4E | |
| SCHEMBL17419215 | 0.97 | STAT3 (0.43) | STAT3STAT1KCNH2GPR84KDM4E | |
| SCHEMBL29910098 | 0.96 | STAT3 (0.39) | STAT3STAT1KCNH2GPR84KDM4E | |
| SCHEMBL4551743 | 0.96 | STAT3 (0.44) | STAT3STAT1KCNH2GPR84KDM4E | |
| SCHEMBL3527775 | 0.95 | STAT3 (0.43) | STAT3STAT1KDM4EHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060293249-A1 | Porphyrin derivatives | PHOTOBIOTICS LIMITED | 2006-12-28 | — | — | US | disclosed |
| EP-1562951-A2 | PORPHYRIN DERIVATIVES | Photobiotics Ltd. (GB) | 2005-08-17 | — | — | EP | disclosed |
| WO-2004046151-A2 | PORPHYRIN DERIVATIVES | PHOTOBIOTICS LIMITED (GB) | 2004-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060293249-A1 | Porphyrin derivatives | SLC2A3, SLC2A2, SCO2 | STAT3 797/4885STAT1 1512/4885KCNH2 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.